Hemovigilance in a Brazilian Amazon blood center: A temporal analysis of 5-year consumption patterns
Cristie Hellen Alves Cascaes1, Thayenne Ribeiro Alves2, Jônatas Alencar Castro Campelo3
1Universidade Estacio de Sá - Campus Amazonas, Manaus, Amazonas, Brazil.
Background:
The transfusion of blood components remains a cornerstone in the management of hematological and onco-hematological diseases. Effective blood bank management, combined with the development of predictive models for component utilization, is essential to anticipate local demands, optimize resource allocation, and support the formulation of evidence-based public health strategies.
Aims:
To analyze temporal trends in the consumption of blood components at a reference center in the Brazilian Amazon over a five-year period (2019-2023) and to develop predictive models to forecast future demand.
Methods:
Transfusion records from the Outpatient and Inpatient Departments were retrospectively collected and categorized by component type. Time-series and regression analyses were applied to assess consumption dynamics. Machine learning models using Auto Regressive Integrated Moving Average and Random Forest algorithms were employed to predict future blood demand.
Results:
Overall transfusion demand decreased during the study period; however, irradiated platelet concentrates, cryoprecipitate, and plasma by apheresis showed significant increases, particularly in the Inpatient Unit. These components are predominantly indicated for immunosuppressed patients, such as those undergoing chemotherapy or bone marrow transplantation.
Conclusion:
The rising demand for irradiated components reflects the clinical complexity of patients treated in a regional hemotherapy referral center. The findings of this study highlight the importance of forecasting tools in supporting transfusion safety, optimizing blood bank management, and guiding public health strategies in the Amazon.
Related Concept Videos
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Bioavailability Study Design: Healthy Subjects Versus Patients
Drug Binding to Blood Components
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are further...
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Blood Transfusion
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

